Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer

Carcinogenesis

Volumn 28, Issue 5, 2007, Pages 1040-1045

  Pylkäs, Katri ^h   Tommiska, Johanna ^a   Syrjäkoski, Kirsi ^b   Kere, Juha ^c,d   Gatei, Magtouf ^e   Waddell, Nicola ^e   Allinen, Minna ^h   Karppinen, Sanna Maria ^h   Rapakko, Katrin ^h   Kääriäinen, Helena ^f   Aittomäki, Kristiina ^a   Blomqvist, Carl ^a   Mustonen, Aki ^h   Holli, Kaija ^g   Khanna, Kum Kum ^e   Kallioniemi, Olli Pekka ^b,f   Nevanlinna, Heli ^a   Winqvist, Robert ^h  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d KAROLINSKA INSTITUTE   (Sweden)

^e QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^f UNIVERSITY OF TURKU   (Finland)

^g UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^h UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; ATM PROTEIN; GLYCINE; PROLINE; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; PROTEIN SERINE THREONINE KINASE; TUMOR SUPPRESSOR PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER SUSCEPTIBILITY; CAUSAL ATTRIBUTION; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FOUNDER EFFECT; GENE INSERTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GEOGRAPHIC DISTRIBUTION; HETEROZYGOTE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STATISTICAL SIGNIFICANCE; ATAXIA TELANGIECTASIA; BREAST TUMOR; FEMALE; FINLAND; GENETICS; MALE; MUTATION; PEDIGREE; PHYSIOLOGY;

ATAXIA TELANGIECTASIA; BREAST NEOPLASMS; CELL CYCLE PROTEINS; COHORT STUDIES; DNA-BINDING PROTEINS; FEMALE; FINLAND; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MUTATION; PEDIGREE; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS;

EID: 34447096911     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl237     Document Type: Article

References (31)

1. Pharoah, P.D.P. et al. (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat. Genet., 31, 33-36.
2. Shiloh, Y. (2003) ATM and related protein kinases: Safeguarding genome integrity. Nat. Rev. Cancer, 3, 155-168.
3. Lavin, M.E et al. (1997) The genetic defect in ataxia-telangiectasia. Annu. Rev. Immunol., 15, 177-202.
4. Swift, M. et al. (1987) Breast and other cancers in families with ataxiatelangiectasia. N. Engl. J. Med., 316, 1289-1294.
5. Olsen, J.H. et al. (2001) Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. J. Natl Cancer Inst., 93, 121-127.
6. Khanna, K.K. et al. (2004) ATM and genome maintenance: Defining its role in breast cancer susceptibility. J. Mammary Gland Biol. Neoplasia, 9, 247-262.
7. Gatti, R.A. et al. (1999) Cancer risk in ATM heterozygotes: A model of phenotypic and mechanistic differences between missense and truncating mutations. Mol. Genet. Metab., 68, 419-423.
8. Bakkenist, C.J. et al. (2003) DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature, 421, 499-506.
9. Cavaciuti, E. et al. (2005) Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families. Genes Chromosomes Cancer, 42, 1-9.
10. Thompson, D. et al. (2005) Cancer risks and mortality in heterozygous ATM mutation carriers. J. Natl Cancer Inst., 97 813-822.
11. Laake, K, et al. (2000) Characterization of ATM mutations in 41 nordic families with ataxia telangiectasia. Hum. Mutat., 16, 232-246.
12. Allinen, M. et al. (2002) ATM mutations in Finnish breast cancer patients. J. Med. Genet., 39, 192-196.
13. Heikkinen, K. et al. (2005) Association of common ATM polymorphism with bilateral breast cancer. Int. J. Cancer, 116, 69-72.
14. Chenevix-Trench, G. et al. (2002) Dominant negative ATM mutations in breast cancer families. J. Natl Cancer Inst., 94, 205-215.
15. Thorstenson, Y.R. et al. (2003) Contributions of ATM mutations to familial breast and ovarian cancer. Cancer Res., 63, 3325-3333.
16. Renwick, A. et al. (2006) ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat. Genet., 38, 873-875.
17. Körkkö, J. et al. (1998) Conformation sensitive gel electrophoresis for simple and accurate detection of mutations: comparison with denaturing gradient gel electrophoresis and nucleotide sequencing. Proc. Natl Acad. Sci., 95, 1681-1685.
18. Syvänen, A.C. et al. (1993) Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing. Am. J. Hum. Genet., 52, 46-59.
19. Shayeghi, M. et al. (1998) Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients. Br. J. Cancer, 78, 922-927.
20. Vahteristo, P. et al. (2002) A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am. J. Hum. Genet., 71, 432-438.
21. Teraoka, S.N. et al. (2001)Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history. Cancer, 92, 479-487.
22. Laake, K. et al. (1997) Loss of heterozygosity at 11q23.1 in breast carcinomas: Indication for involvement of a gene distal and close to ATM. Genes Chromosomes Cancer, 18, 175-180.
23. Broeks, A. et al. (2000) ATM-heterozygous germ line mutations contribute to breast cancer-susceptibility. Am. J. Hum. Genet., 66, 494-500.
24. Bosotti, R. et al. (2000) FAT: A novel domain in PIK-related kinases. Trends Biochem. Sci., 25, 225-227.
25. Stankovic, T. et al. (1998) ATM mutations and phenotypes in ataxiatelaugiectasia families in the British Isles: Expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer, Ant J. Hum. Genet., 62, 334-345.
26. Dörk, T. et al. (2001) Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients. Cancer Res., 61, 7608-7615.
27. Morgan, S.E. et al. (1997) Fragments of ATM which have dominant-negative or complementing activity. Mol. Cell Biol., 17, 2020-2029.
28. Delia, D. et al. (2000) ATM protein and p53-serine 15 phosphorylation in ataxia-telangiectasia (AT) patients and at heterozygotes. Br. J. Cancer, 82, 1938-1945.
29. Fernet, M. et al. (2004) Cellular responses to ionising radiation of AT heterozygotes: Differences between missense and truncating mutation carriers. Br. J. Cancer, 90, 866-873.
30. Gatei, M. et al. (2003) Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation. J. Biol. Chem., 278, 14806-14811.
31. Lee, J.H. et al. (2004) Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science, 304, 93-96.